Imiquimod is a topical immune response modifier used to treat anogenital warts. Although considered a safe drug, mild to moderate local and systemic side-effects may occasionally occur. We report three cases of local and systemic adverse effects related to imiquimod, including one case that mimicked meningitis, which promptly resolved with drug cessation.
TrottierH, FrancoEL.The epidemiology of genital human papillomavirus infection.Vaccine2006; 24 (Suppl. 1): S1–15.
2.
EdwardsL, FerenczyA, EronL.Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human papillomavirus.Arch Dermatol1998; 134: 25–30.
3.
The Electronic Medicines Compendium (eMC).eMC, Aldara 5% Cream -Summary of Product Characteristics.Surrey: Datapharm Communications Limited, 2010
4.
OwensML, BridsonWE, SmithSL.Percutaneous penetration of Aldara cream, 5% during the topical treatment of genital and perianal warts.Prim Care Update Obstet Gynecol1998; 5: 151
5.
MooreRA, EdwardsJE, HopwoodJ, HicksD.Imiquimod for the treatment of genital warts: a quantitative systematic review.BMC Infect Dis2001; 1: 3
6.
KumarB, NarangT.Local and systemic adverse effects to topical imiquimod due to systemic immune stimulation.Sex Transm Infect2011; 87: 432
7.
KulpJ, LevyS, FeinMC.Pharmacokinetics of imiquimod 3.75% cream applied daily for 3 weeks to actinic keratoses on the face and/or balding scalp.Arch Dermatol Res2010; 302: 539–44.
8.
DammJ, WiegandF, HardenLM.Fever, sickness behavior, and expression of inflammatory genes in the hypothalamus after systemic and localized subcutaneous stimulation of rats with the toll-like receptor 7 agonist imiquimod.Neuroscience2012; 201: 166–83.
